1. Seth HD, Sultan S, Gotfried MH. Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease. J Thorac Dis. 2013;5(6):806–14.
2. Global Strategy for the Diagnosis, Management, and Prevention of COPD, GOLD 2016.
3. Boyd G, Morice AH, Pounsford JC, Siebert M, Peslis N, Crawford C. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J. 1997;10(4):815–21.
4. Cazzola M, Matera MG, Santangelo G, Vinciguerra A, Rossi F, D’Amato G. Salmeterol and formoterol in partially reversible severe chronic obstructive pulmonary disease: a dose–response study. Respir Med. 1995;89(5):357–62.
5. Rossi A, Kristufek P, Levine BE, Thomson MH, Till D, Kottakis J, Della Cioppa G, Formoterol in Chronic Obstructive Pulmonary Disease IISG. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD. Chest. 2002;121(4):1058–69.